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ABSTRACT 
The major cell surface glycoprotein of chick embryo fibroblasts, cellular fibronec- 
tin (formerly known as CSP or LETS protein), was purified and used to produce 
monospecific antisera. After affinity purification, the anti-fibronectin was used to 
investigate fibronectin's localization, its transfer from intracellular to extracellular 
pools, its antibody-induced redistribution on the cell surface, and its role in cell 
shape. 
Anti-fibronectin  localizes  to  extracellular  fibrils  located  under  and  between 
sparse  cells,  and  to  a  dense  matrix  that  surrounds  confluent  cells.  Cellular 
fibronectin is also present in granular intracytoplasmic structures containing newly 
synthesized fibronectin before secretion. This intracellular staining disappears 2 h 
after treatment  with cycloheximide or puromycin,  and returns  after removal of 
these  protein  synthesis inhibitors.  In  pulse-chase  experiments  using  cyclohexi- 
mide, fibronectin was sequentially transferred from the intracellular to the fibrillar 
extracellular forms. 
Transformation  of chick fibroblasts results  in  decreases in both extracellular 
and  intracellular  fibronectin,  and  in  altered  cell  shape.  Treatment  of untrans- 
formed chick fibroblasts with anti-fibronectin results in rapid (30 min) alteration 
to a rounder cell shape resembling that of many transformed cells. These rapid 
shape changes are followed by a  slow, antibody-induced redistribution of fibro- 
nectin to supranuclear caplike structures. This "capping" is inhibited by metabolic 
inhibitors. 
Reconstitution of cell surface fibronectin onto transformed cells restores a more 
normal  fibroblastic  phenotype.  The  reconstituted  fibronectin  on  these  cells 
organizes into fibrillar patterns similar to those of untransformed  cells. As with 
untransformed  cells, treatment  of these reconstituted cells with anti-fibronectin 
also results in cell rounding and "capping" of fibronectin. 
KEY  WORDS  fibronectin  A  glycoprotein of high molecular weight has been 
immunofluorescence  antibody-induced  identified on the surface of a variety of fibroblastic 
redistribution  ￿9  secretion  adhesion  and epithelial cells in vitro, using procedures that 
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pounds  or  by  specific  antibodies  (reviewed  in 
references 15, 44, 55: see also reference 7). This 
glycoprotein  is  known  as  cell  surface  protein 
(CSP),  large,  external,  transformation-sensitive 
(LETS)  protein,  or  cellular fibronectin (16,  21, 
58). This protein is often decreased after establish- 
ment of a permanent cell line (61), and is usually 
further decreased  after neoplastic transformation 
(15,  44,  55).  Cells missing this glycoprotein are 
generally tumorigenic (7,  12),  although  in vitro 
experiments  indicate  that  it  does  not  directly 
control growth rates (43, 60). 
This glycoprotein, or the immunologically indis- 
tinguishable plasma glycoprotein "cold  insoluble 
globulin" (plasma fibronectin) is thought to be a 
constituent  of  connective  tissue  and  possibly of 
basement membranes in vivo  (27,  44).  Both  of 
these proteins may mediate adhesive interactions 
of cells with  substrata  in vitro  and in vivo.  For 
example,  they  promote  cell  attachment  and 
spreading on plastic, glass, and collagen substrate 
(3, 13, 23, 24, 34, 60). 
We have isolated fibronectin from chick fibro- 
blasts, and have established that it is an adhesive 
protein (54,  58, 59, 60).  Reconstituting this pro- 
tein  on  the  surfaces  of  transformed  cells  from 
several species results in morphologic reversion to 
a more normal phenotype, apparently because of 
increased cell adhesion (3, 53, 54, 60). 
We  previously  reported  that  an  antibody  di- 
rected against fibronectin inhibited its hemagglu- 
tinating activity (59)  and the fibronectin-induced 
reversion of transformed cells (60: see also refer- 
ence 3). This antibody also readily crossed species 
lines and stained the  cell surface  fibronectins of 
chick, human, mouse, rat, and hamster fibroblasts 
(61).  In  this  paper,  I  describe  the  preparation, 
characterization, and a further purification of this 
antibody by affinity chromatography. The affinity- 
purified antibody is used to explore  the  localiza- 
tion, the intracellular-to-extracellular movement, 
the  antibody-induced redistribution, and the role 
in  cell  morphology  in  vitro  of  this  cell  surface 
glycoprotein. 
MATERIALS  AND  METHODS 
Electrophoretic Purification of Cellular 
Fibronectin 
Fibronectin was isolated from tertiary chick embryo 
fibroblasts cultured in roller  bottles,  using extraction 
with 1 M urea as described previously (54, 59, 60). The 
fibronectin was further purified either by electrophoresis 
or by column chromatography. For electrophoresis,  the 
extracts  were dialyzed against deionized water (3 x  4 l 
for 72 h), lyophilized,  then resuspended in 2% sodium 
dodecyl  sulfate  (SDS)  and 0.1  M  dithiothreitol in 10 
mM phosphate, pH 7.0. Samples were heated at 100~ 
for 3 rain, incubated for 30 min at 37~  to complete 
reduction, and electrophoresed on 5%  polyacrylamide 
slab SDS gels as described previously (40, 58), with the 
substitution of a single-well spacer to form the sample 
well of a 1-mm thick preparative slab gel. 
The following precautions, adapted from Weber and 
Kuter  (49)  and  Weiner et  al.  (50),  were  utilized  to 
permit optimal recovery of antigen. (a) Preparative gels 
were  stored, for 3-4 days before use, in a humidified 
plastic bag to permit complete polymerization. (b) Gels 
were  pre-electrophoresed with  0.01%  crystal  violet to 
serve to trap possible free radicals,  then further electro- 
phoresed for twice the usual electrophoresis  time (total 
of  3  h  more)  with  a  total  of  three  changes  of  the 
electrode  buffer.  (c)  Gels  were  not  fixed  or  stained 
before slicing, inasmuch as these treatments were found 
to decrease the recovery of large proteins from SDS gels. 
After electrophoresis,  three vertical reference slices 
3-5 mm wide were cut from the slab gel, stained for 5 
min with  0.25%  Coomassie  Blue (ICI United States, 
Inc., Wilmington, Del.) in 50% TCA, and destained in 
7% acetic acid; meanwhile, the remainder of the gel was 
stored to 4~  to decrease  protein diffusion. The mobility 
of the CSP band was determined, and the appropriate 
region was sliced from the gel with a pizza cutter. The 
gel was triturated with a glass rod and the protein was 
eluted with 0.05% SDS in 5 mM ammonium bicarbon- 
ate with continuous agitation at 37~  After 18 h, the 
extract was centrifuged to remove gel fragments, lyophi- 
lized,  resuspended  in  deionized  water,  and  dialyzed 
against 0.05% SDS to decrease  the SDS concentration. 
Purity was assessed  by staining the remnants of the 
gel to ensure that only the fibronectin region was  re- 
moved (three runs were  discarded  at this step), and by 
re-electrophoresis  of the  eluted  antigen on  analytical 
gels. Quantities of fibronectin were determined by den- 
sitometry of the Coomassie  Blue staining of aliquots of 
purified fibronectin in gels  that  also  included parallel 
lanes  containing bovine serum  albumin protein  stan- 
dards. 100-150/~g of fibronectin were injected at 4-wk 
intervals into two goats to complete Freund's adjuvant, 
then twice  more in incomplete Freund's adjuvant. 10 
days after the last injection, serum was collected.  Addi- 
tional serum was obtained 1 yr later from one goat after 
three more booster injections. 
Column Chromatography 
Isolated fibronectin was precipitated with 70% satu- 
rated ammonium sulfate, then resuspended at 2-5 mg/ 
ml in buffer B (50 mM cyclohexylaminopropane  sulfonic 
acid [CAPS],  0.1 M NaC1, l  mM CaCI~, 1 mM phenyl- 
methylsulfonyl  fluoride [PMSF]), and the pH rapidly re- 
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against  buffer  B  for  18  h  with  two  changes,  then 
centrifuged at 25,000 g for 15 min. The fibronectin was 
chromatographed at 4~  on a  2.5  x  100-cm upward- 
flow column of cross-linked Sepharose 4B  (Pharmacia 
Fine  Chemicals,  Inc.,  Uppsala,  Sweden)  pre-equili- 
brated  with buffer B.  Fractions comprising the  dimer 
peak  of  fibronectin  described  previously  (56)  were 
pooled and either used for injection as an antigen into a 
goat  (150  /~g  per  injection using  the  same  schedule 
described for electrophoretically purified fibronectin), or 
covalently attached to Sepharose for affinity purification 
of anti-fibronectin antibodies. 
Affinity Purification of Antibody 
3 mg of fibronectin dimer prepared from cells prela- 
beled with mI (14) was reacted with 3 g of cyanogen- 
bromide-activated  Sepharose  4B  (Pharmacia  Fine 
Chemicals, Piscataway, N.J.) for 2 h at room tempera- 
ture  in  0.1  M  borate,  pH  10.0,  and  0.5  M  NaC1. 
Triethylamine was added to stop the reaction, and the 
slurry was washed according to the manufacturer's rec- 
ommendations. 83% of the fibronectin remained bound 
to the  agarose  as determined using a  gamma counter. 
The agarose-fibronectin was poured as a 0.9-cm diame- 
ter column, and further washed before use according to 
the protocol used for antibody purification (see below). 
A second affinity column using 6 mg of fibronectin dimer 
was prepared in the same manner. 
Antiserum  was  precipitated  three  times  with  40% 
saturated ammonium sulfate, dialyzed against PBS, and 
a  10-ml  aliquot containing -50  mg/ml of protein was 
applied  over  a  2-h  period  to  the  fibronectin-agarose 
column.  Unretained and nonspecifically adsorbed pro- 
teins were eluted by a 20-ml wash with PBS followed by 
three cycles of 4 column volumes each of 0.1 M sodium 
acetate (pH 4.8) plus 0.5 M NaC1,  alternating with 0.1 
M  sodium borate (pH 8.5) plus 0.5 M NaCI. Antibody 
was eluted with 0.2 M  acetic acid (pH 2.5) with 0.5 M 
NaCI. Each 1.0-ml fraction was neutralized immediately 
with NaOH, the protein peak as determined by absorb- 
ance at 280 nm was pooled, and antibody was precipi- 
tated  with  50%  saturated  ammonium  sulfate.  After 
centrifugation, resuspension in PBS, and dialysis  for 24 
h  against three  changes  of  PBS,  the  affinity-purified 
antibody was adjusted to 1 mg/ml and stored at -20~ 
In  a  typical  preparation,  15  mg of antibody were  re- 
covered from 1,600 mg of globulin. 
Control sera consisted of the corresponding pre-im- 
munization sera as well as a non-immune control serum 
from a  goat that had been injected with another unre- 
lated,  electrophoretically-purified antigen  (platelet  ac- 
tin). The latter non-immune control serum contained no 
detectable antibodies by immunodiffusion or immuno- 
precipitation analyses of cell homogenates, and did not 
stain acetone-fixed cells;  it serves as  a  control for the 
residual  SDS  and  acrylamide,  as well as  the  Freund's 
adjuvant with which goats are  injected along with the 
fibronectin. The immunoglobulin G  (IgG) fractions of 
these sera were afffinity-purified  using a column of 10 mg 
of rabbit anti-goat IgG  (containing 2.0  mg of specific 
antibody)  coupled  to  Sepharose,  following  the  same 
procedures used for purifying the anti-fibronectin anti- 
body. 
Fab Fragments and Other Antibodies 
Fab fragments of anti-fibronectin were  prepared by 
papain cleavage  (30,  35) followed by gel and affinity 
chromatography.  The  ammonium-sulfate-fractionated 
globulin fraction of anti-fibronectin was digested with a 
1:200  (wt/wt)  ratio  of  mercuripapain  to  antibody  as 
described by Notkins et al. (30). The digest was alkyl- 
ated with iodoacetic acid (30) to inactivate the papain, 
then dialyzed against 0.1  M  potassium phosphate, pH 
7.5,  for  18 h. After centrifugation at 25,000 g  for  10 
min, the  supernate was  chromatographed on a  2.5  x 
100-cm  Sephadex G-100 column  as described by An- 
toine  et  al.  (4).  The  void  volume  containing a  small 
amount of uncleared antibody was discarded. Fractions 
from the Fab peak were pooled, precipitated with 70% 
ammonium sulfate, and affinity-purified on a fibronectin 
dimer-Sepharose column as described earlier. The final 
Fab  preparation  contained no  detectable  residual  un- 
cleaved heavy chain by SDS gel electrophoresis. 
Anti-filamin antiserum was produced by a series of six 
injections of 150/xg each of chicken gizzard filamin into 
a goat following the protocol described above for fibro- 
nectin. The filamin was a  gift from Drs. Peter Davies, 
Yutaka Shizuta, and Ira Pastan, and the antibody was 
used previously in studies of filamin by Davies et al. (8). 
Anti-L-cell  myosin  was  a  kind  gift  from  Dr.  Mark 
Willingham and Dr. Ira Pastan. 
Immuno  fluorescence and 
Phase- Contrast Microscopy 
Chick embryo fibroblasts were established, cultured, 
and passaged using 0.25%  trypsin as described previ- 
ously (32, 47) in Ham's F10 medium supplemented with 
5% heat-inactivated calf serum and 10% tryptose phos- 
phate  broth.  Chick  fibroblasts in  the  third  or  fourth 
passage were plated at 1 ￿  1@ cells/35-mm plastic tissue 
culture  dish on  cover slips  sterilized by  incubation in 
95%  ethanol and  flaming.  After  2  days  at  37~  in a 
humidified  5%  CO2-95%  air  mixture,  cultures  were 
rinsed once with  Dulbecco's phosphate-buffered saline 
(PBS) with calcium and magnc~h,m, then fixed for 1 h in 
2%  formaldehyde  or  paraformaldehyde  in  PBS  with 
Ca ++ and Mg  +§ containing 1% sucrose to decrease cell 
blebbing. Fixed cultures were then rinsed three times in 
PBS and either extracted with acetone or used directly 
without permeabilization. 
To  extract  with  acetone,  cells  on  cover  slips  were 
immersed in  1:1  (vol/vol) acetone-water at  0~  for  2 
min, acetone at -20~  for 2 min, 1:1 acetone-water for 
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drying. 
For indirect immunofluorescence, cultures were incu- 
bated at 22~176  with goat antibody in PBS for 1 h at 
the  concentrations  indicated  in  the  text, rinsed  for 30 
min in four changes of PBS, then incubated for 1 h with 
a  1:10 dilution in PBS of fluorescein-labeled rabbit IgG 
directed against goat IgG heavy and light chains (fluores- 
cein:protein molar ratio =  4.3; Miles Laboratories Inc., 
Elkhart,  Ind.).  After rinsing  for  30  min  in  PBS,  the 
backs of the cover slips were rinsed with deionized water 
and  blotted  dry,  and  the  cover  slip  was  mounted  in 
phosphate-buffered glycerol mounting medium. 
Alternatively, antibody was labeled directly with  flu- 
orescein  using  1  mg of fluorescein isothiocyanate/100 
mg of protein for 2 h at 23~  followed by chromatog- 
raphy  on  Sephadex  G-25  in  PBS  to  separate  labeled 
protein from free dye (19). The final fluorescein:protein 
molar  ratio  was  3.5.  If  cells  were  stained  with  this 
antibody,  the  second  anti-immunoglobulin  step  was 
omitted. 
Cells were examined on a  Zeiss fluorescence micro- 
scope  equipped  with  a  BGI2  exciter  and  a  500-nm 
barrier filter. Photographs were taken with Polaroid 107 
film, ASA 3000  (Polaroid  Corp.,  Cambridge,  Mass.), 
and used directly for figures. Unless otherwise indicated, 
the fluorescence micrographs were obtained using a 40￿ 
non-phase-contrast  objective  of  numerical  aperture 
(NA) 1.0 with exposure times of 10-15 s. All exposure 
times were identical within each series in which compar- 
isons  of intensities  of staining  were  made.  Dark-field 
microscopy could  be  performed  on  the  same  cells  by 
using  a  Zeiss Ultra-dark-field oil immersion condenser 
(NA 1.2/1.4) after partial closure of an iris diaphragm in 
the 40￿  objective. 
A  Zeiss lnvertoscope D  was  utilized for the phase- 
contrast  micrographs,  using  Panatomic  X  35  mm film 
(Eastman  Kodak  Co.)  and  a  green filter. Cell area of 
cells fixed for 1 h with glutaraldehyde-paraformaldehyde 
exactly  as  described  (57)  was  measured  as  described 
previously (60), using a 10 ￿  10  eyepiece grid. 
Materials 
Sepharose  CL-4B,  Sephadex  G-25  and  G-100,  and 
cyanogen-bromide-activated  Sepharose  4B  were  pur- 
chased  from  Pharmacia  Fine Chemicals, Inc.); CAPS, 
PMSF,  cycloheximide,  puromycin,  and  triethylamine 
from  Sigma Chemical Co.,  St.  Louis,  Mo.; crystalline 
trypsin  and mercuripapain from Worthington Biochemi- 
cal Corp., Freehold, N.J.; colchicine from Calbiochem, 
La Jolla, Calif.; and.cytochalasin B and iodoacetic acid 
from Aldrich Chemical Co., Inc., Milwaukee, Wis. 
Heat-inactivated calf serum was purchased from Flow 
Laboratories,  Inc.,  Rockville, Md.,  and  tissue  culture 
dishes  from  BioQuest,  BBL,  &  Falcon  Products,  Ox- 
nard,  Calif.  or  Corning  Glass  Works,  Coming,  N.Y. 
Fluorescein-labeled IgG fraction of rabbit anti-goat lgG, 
the  unlabeled  IgG  fraction  of  rabbit  anti-goat  lgG, 
incomplete and  complete Freund's adjuvant, and fluo- 
rescein isothiocyanate were obtained from Miles Labo- 
ratories Inc., FA mounting medium, pH 7.2, from Difco 
Laboratories, Detroit, Mich., and 6-well pattern  C im- 
munodiffusion  plates  from  Hyland  Diagnostics  Div., 
Travenol Laboratories,  Inc.,  Costa  Mesa,  Calif. L-[U- 
14C]leucine  (287  and  314  mCi/mmol),  L-[U- 
14C]methionine  (213  mCi/mmol), and  L-[U-~4C]proline 
(261  mCi/mmol)  were  obtained  from  New  England 
Nuclear, Boston, Mass. 
RESULTS 
Specificity of the Antibody 
The cellular fibronectin used as immunogen was 
homogeneous by SDS polyacrylamide gel electro- 
phoresis  (Fig.  1).  Cellular fibronectin is not solu- 
ble  under the conditions usually used to evaluate 
antibody  specificity  (17,  56).  We  therefore  first 
solubilized the fibronectin by elevating the pH to 
11.0  (32,  56),  then  assayed  for  specificity  at 
neutral  pH.  In Ouchterlony double immunodiffu- 
sion  gels,  confrontation  of either  antibody  (anti- 
fibronectin dimer or anti-electrophoretically puri- 
fied fibronectin) with either isolated fibronectin or 
homogenates  of cultures  of chick  embryo  fibro- 
blasts resulted in a single immunoprecipitin line of 
identity  (Fig.  2).  If cultures  of chick  fibroblasts 
were  trypsinized  before  homogenization  to  re- 
move external fibronectin (58) or transformed  by 
Rous sarcoma virus, the remaining precipitin line 
retained a junction of identity with the fibronectin 
of untrypsinized  cultures  (Fig.  2).  The  antibody 
did not form precipitin lines when confronted with 
calf or fetal calf serum, chicken gizzard filamin, or 
L-cell  myosin,  but  did  readily  cross-react  with 
chicken  serum  or  plasma  (Fig.  2:  unpublished 
results). The reactive material in chicken serum is 
probably  chicken plasma  fibronectin  (37:  K.  Ya- 
FIGURE  1  SDS-polyacrylamide  gel  electrophoresis  of 
cellular fibronectin preparation used as antigen. Electro- 
phoretically purified fibronectin analyzed on a 5% poly- 
acrylamide SDS gel and  stained for protein with  Coo- 
massie  Brilliant Blue, and densitometer scan of this gel 
showing absorbance at 550 nm. 
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cellular fibronectin antibody. (a) Center well: 1.5 mg/ml 
of purified cellular fibronectin  in 0.15  M NaC1, 1 mM 
CaCI~, 50 mM CAPS buffer,  pH 11.0.  (1) Anti-fibro- 
nectin  antiserum,  1:10  dilution  in  PBS.  (2)  Affinity- 
purified  anti-fibronectin,  0.5  mg/ml.  (3) Control  non- 
immune  serum,  1:10.  (4) Antifilamin antiserum,  1 :  10. 
(5)  Anti-L-cell  myosin  antiserum  1:10.  Stained  with 
Coomassie Blue. (b) Center well: unfractionated antise- 
rum against electrophoretically purified cellular fibronec- 
tin, 1:5 dilution. (1)cellular fibronectin,  1.5 mg/ml. (2) 
Chicken  serum,  undiluted. (3) Calf serum,  undiluted. 
(4) cellular fibronectin,  1.5 mg/ml. (5) Fetal calf serum, 
undiluted. (c) Center well: unfractio.nated anti-fibronec- 
tin, 1:10 dilution. (1)Purified cellular fibronectin, 1 mg/ 
ml. (2) Homogenate of chick embryo fibroblasts, 5 mg/ 
ml in  1% Triton X-100  (Rohm & Haas Co., Philadel- 
phia, Pa.), 50 mM CAPS buffer, pH 11. (3) Homoge- 
nate of chick fibroblasts that had been pretreated with 
10  /zg/ml of trypsin  for  10  rain  at  37~  5 mg/ml  in 
Triton-CAPS. (4) Homogenate of Rous sarcoma virus- 
transformed  chick fibroblasts, 8 mg/ml in Triton-CAPS. 
(5) Chicken serum, undiluted. 
mada. Unpublished results). Conversely, goat an- 
tibodies against chicken gizzard filamin or mouse 
L-cell myosin did not react with purified cellular 
fibronectin (Fig. 2). 
Because Keski-Oja et al. (22) had reported that 
their  antibody against  surface  papain  digests of 
chick  fibroblasts formed  a  single  line  in  double 
immunodiffusion tests  against cell homogenates, 
yet  appeared  to  react  with  at  least  two  distinct 
polypeptides of tool wt  210,000  and  145,000  in 
immunopreeipitation  experiments,  the  antibody 
was further examined for specificity by immuno- 
precipitation of homogenates of chick fibroblasts. 
Cultures  of chick  fibroblasts were  pulse-labeled 
with  10  /~Ci/ml  [14C]leucine,  [14C]methionine, or 
[x4C]proline for 15 or 30 rain each, then homoge- 
nized  at  pH  11  and  immunoprecipitated as  de- 
scribed previously (32).  After electrophoresis of 
the  immunoprecipitate  on  SDS  gels,  label  was 
found almost entirely in the fibronectin band, and 
not in any other region of the gel other than at the 
front of the  immunoglobulin light chain band in 
both control and anti-fibronectin immunoprecipi- 
tates  (Fig.  3).  In  some  immunoprecipitates,  la- 
beled for 24 h with  [14C]leucine,  bands co-migrat- 
ing  with  actin  and  myosin were  found  in  equal 
amounts  in  gels  of  anti-fibronectin  and  control 
sera  (Fig.  3)  (32),  apparently representing non- 
specific precipitation. A  heavily labeled band  of 
mol wt  160,000  present in cell homogenates was 
not precipitated by anti-fibronectin antibody. 
Immunofluorescence  Localization:  Extracel- 
lular Fibronectin 
Cells fixed with formaldehyde or paraformalde- 
hyde exclude antibody unless extracted with ace- 
tone.  When  chick fibroblasts at  low cell density 
(<5  ￿  104 cells/cm  z) are fixed under these condi- 
tions and stained with afffinity-purified anti-fibro- 
nectin (20/zg/ml) without acetone extraction, the 
fluorescence is localized to fibrils under  and be- 
tween cells (Fig. 4a'). This extracellular fibronec- 
tin  does not usually extend  substantially beyond 
FIGURE 3  Immunoprecipitation  of  cell  homogenates 
by anti-fibronectin. Cultures of chick embryo fibroblasts 
were  labeled with  [t4C]leucine, solubilized, and immu- 
noprecipitated  with  anti-fibronectin  followed  by  anti- 
antibody exactly as described previously in reference 32. 
Scale indicates apparent subunit  mol wt  ￿  10  -3, using 
previously described protein standards  (61). (a-c) Cells 
labeled with  10 /.tCi/ml of [x4C]leucine for 15 rain and 
electrophoresed  using a  stacking  gel  system  (40).  (a) 
Cell homogenate.  (b) Immunoprecipitate  using 45  /xg/ 
ml of affinity-purified anti-fibronectin.  (c) Immunopre- 
cipitate  with  45  /zg/ml of  control  IgG.  (d-e)  Cells 
labeled with  1  /zCi/ml  of  [14C]leucine for  24  h  and 
electrophoresed  in  a  continuous  gel system  (61).  (d) 
Immunoprecipitate  using 1:20 dilution of unfractionated 
anti-fibronectin antiserum in the first step. (e) Immuno- 
precipitate  using  1:20  dilution  of  non-immune  goat 
serum in first step. 
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hyde, incubated with 20/~g/ml of affinity-purified anti-fibronectin,  then anti-IgG labeled with fluorescein. 
(a) Two chick cells, dark-field microscopy.  (a') Same field by immunofluorescence microscopy,  focused 
on the plane of the substratum. (a") Immunofluorescence, focused higher on the cells to show fibronectin 
bridging between cells (arrow). (b) Cell with unusual amount of fibronectin extending to substratum at 
posterior of cell. (c) Cell layer (CL) retracted to the left from a wound; dark-field. (c') Immunofluores- 
cence of same field.  (d)  Fibronectin remaining on substratum after removal of cells  by EDTA and 
pipetting. (e) Fibronectin on cells treated with EDTA, but not dislodged  from the dish. Fig. 4a and c-e 
are x  520. Fig. 4b is a photographically  reduced print, x  350. Bars, 25/xm. 
the outlines of the cells, although fibrils often trail 
out  behind  cells  and  bridge  between  cells  (Fig. 
4a").  Occasionally, long fibrillar tails of fibronec- 
tin (Fig. 4b) or a  "footprint" of a cell outline can 
be seen,  apparently because of a  sudden detach- 
ment of a cell that leaves fibronectin behind. 
In denser cell cultures with  increasing cell-cell 
contact,  the  fibronectin fibrils become  more  fre- 
quent and stain more intensely. The cells become 
surrounded by a  longitudinally oriented, complex 
matrix of extracellular fibrillar material (Fig. 4c-e 
and  5c),  as  described  previously  (3,  7,  28,  48, 
55).  The  affinity of  this  fibronectin  to  the  cell 
layer vs. the affinity to the substratum was tested 
by  the  following  cell  detachment  experiments. 
Cultures were wounded by scratching with a glass 
rod. Cells retracted laterally from the wound, and 
the  amounts  of  fibronectin retracting  with  cells 
were  compared  to  amounts  remaining  on  the 
substratum.  Alternatively,  cells  were  detached 
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buffered saline.  In both cases, most of the fibro- 
nectin  was  found  to  retract  with  the  cell  sheet, 
although weakly staining  networks of fine fibrils 
remained  behind on the substratum  (Fig. 4c-e). 
As previously reported by others (28), the same 
fibrillar, extracellular distributions of proteins are 
also observed if living  cells are stained briefly (5 
min) with  anti-fibronectin,  then with fluorescein- 
labeled anti-IgG, and then examined immediately: 
similar fibrillar staining patterns are also obtained 
using anti-fibronectin directly labeled with fluores- 
cein or rhodamine (38: K. Yamada. Unpublished 
results). 
Intracellular  Fibronectin 
Cells  were  extracted  with  acetone  to  permit 
intracellular  staining.  In cells  that  had  been cul- 
tured at low cell  density, this procedure resulted 
in  staining  of  vaguely  granular  structures  sur- 
rounding the nucleus, as well as the extracellular 
fibrils described previously (Fig.  5a and b). The 
perinuclear  intracellular  staining  was  excluded 
from large vesicles (Fig. 5 b). Similar intracellular 
staining of chick cells  has been reported by Sten- 
man et al. (39). 
As  the  cultures  became  more  crowded,  the 
intracellular staining became progressively harder 
to detect among the more heavily staining extra- 
cellular fibrils  (Fig. 5 c).  Gentle trypsinization of 
live  cells  (1  tzg/ml  for  5  or  10  min  at  37~ 
removes  the  extracellular,  fibrillar  fibronectin, 
revealing  the  intracellular,  granular  perinuclear 
staining (Fig. 5 d). 
Immunofluorescence Specificity  Controls 
Both  intracellular  and  extracellular  staining 
were specific in that no staining was found when 
an  equal  amount  of the  affinity-purified control 
antibody, crude gamma globulin from this control 
serum,  or pre-immune  serum was used  (Fig.  5e 
and f). Procedures designed to inhibit nonspecific 
adsorption of antibody, such as pre-incubation of 
cells  in 25 mg/ml bovine serum albumin or 50% 
non-immune rabbit serum, plus addition of these 
proteins to all antibody staining solutions, did not 
affect  the  intracellular  staining.  Finally,  pre-ab- 
sorption of the anti-fibronectin with purified cel- 
lular fibronectin dimer (1:4 or higher wt:wt ratios 
of fibronectin  to  antibody  protein)  blocked  the 
staining of cells (Fig. 5g). 
Extracellular  staining  was  distinguished  from 
intracellular staining by the criteria of (a) sensitiv- 
ity to removal by mild protease treatment of cells 
before fixation and staining: these conditions were 
previously shown to remove all extracellular fibro- 
nectin detectable  by iodination  (58, 61), without 
affecting amounts of intracellular  fibronectin de- 
tected by biochemical criteria (32): and (b) pres- 
ence on live or fixed cells  before acetone extrac- 
tion.  Formaldehyde-fixed  cells  were  shown  to 
remain  impermeable  to intracellular  diffusion of 
antibody by attempting to stain with  antifilamin: 
no  staining  was  detected  unless  cells  were  first 
extracted with acetone. 
The  intracellular  staining  was characteristic  in 
that it was (a) not decreased in apparent intensity 
by external  protease  treatment  of cells:  (b)  de- 
tected only after cells were extracted with acetone 
or detergents;  and  (c)  absent  after  inhibition  of 
protein synthesis.  In addition,  intracellular fibro- 
nectin  could  usually  also  be  distinguished  from 
external fibronectin by continuously changing the 
focal plane of the microscope to determine stain- 
ing inside the plasma membrane and adjacent to 
the nucleus. 
The immunofluorescence patterns were not due 
to immunological cross-reactive materials such as 
plasma  fibronectin  (cold  insoluble  globulin)  de- 
rived  by  the  cells  from  the  calf serum  used  in 
culture media:  (a) Anti-fibronectin did not react 
with  calf serum  in double  immunodiffusion tests 
(Fig.  2):  (b)  anti-fibronectin  absorbed  with  calf 
serum  (100  ~tg/ml  of affinity-purified anti-fibro- 
nectin plus 90% calf serum for 1 h at 23~  then 
centrifuged at  10,000 g for 10 min) was as effec- 
tive  as  unabsorbed  anti-fibronectin  in  staining 
intracellular  and  extracellular  fibronectin  when 
used  at  20  /xg/ml  to  stain  fixed  cells  with  or 
without acetone extraction; and  (c) fluorescence 
localization patterns were not altered if cells were 
plated  into  medium  containing  5%  pre-immune 
goat serum substituted for the calf serum, cultured 
for 2  days, fixed, acetone-extracted,  and stained 
with  anti-fibronectin  from the  same  goat.  If the 
localization had  been  due  to  a  component from 
calf serum,  this protocol should have  resulted  in 
loss of antibody localization. 
Relationship o  f lntracellular  to 
Extracellular  Fibronectin 
To evaluate  whether  the  intracellular  staining 
could represent newly synthesized fibronectin be- 
fore secretion, cells were treated with inhibitors of 
protein synthesis. Cells in regular culture medium 
526  THE JOURNAL OF CELL BIOLOGY"  VOLUME 78, 1978 FIGURE  5  Fibronectin localization in acetone-treated cells, using 20/~g/ml of all antibodies. (a) Dark 
field. (a') Immunofiuorescence; compare fibrillar fibronectin (arrows) to perinuclear, granular intracellu- 
lar fibronectin. (b) Higher magnification of another cell. (c) Partially confluent culture, dark field. (c') 
Immunofluorescence; note coincidence of borders of fibronectin staining with cell margins (arrowheads). 
(d)  Partially  confluent  culture  trypsinized  with  i  p,g/ml  of  crystalline  trypsin  for  5  rain  to  remove 
extracellular,  fibrillar fibronectin.  (e)  Pre-immune IgG.  (f)  Control  IgG,  described  in  Materials and 
Methods. (g) 20/zg/ml of anti-fibronectin absorbed with 4 p,g/ml of fibronectin dimer for 30 rain at 23~ 
before  incubation with fixed,  acetone-extracted cells. N  =  nucleus, I  =  intracellular fibronectin, V  = 
vesicle. Figs. 5a and c-g are ￿  520; Fig. 5b is x  1,300. Bars, 25/zm. were  exposed  to  2  ~g/ml  cycloheximide,  which 
inhibited  the  incorporation  of  [14C]ieucine  into 
TCA-precipitable  material  by  95%,  then  fixed, 
extracted  with  acetone,  and  stained  with  anti- 
fibronectin.  The  intracellular  staining  progres- 
sively  decreased  in  cycloheximide-treated  cells, 
and was absent from most (>80%) of the cells by 
60 min.  By 120 min,  <2%  of the cells  had any 
detectable intracellular staining (Fig. 6 a, Table I). 
Extracellular  fibronectin  appeared  to  be  unaf- 
fected by this treatment. 
The inhibition of intracellular staining is revers- 
ible.  Removal of cycloheximide after  120 min of 
treatment  resulted  in a progressive reappearance 
of the  intracellular  staining  (Table  I).  Cultures 
from  which  cycloheximide  was  removed,  then 
replaced immediately, showed no return of intra- 
cellular  labeling.  Similar  results  were  obtained 
using puromycin, another protein synthesis inhib- 
itor  (Fig.  6b).  These  results  suggested  that  the 
intracellular  staining was due  to a labile  internal 
pool  of fibronectin,  such  as  a  secretory  antece- 
dent,  rather  than  due  to  ingested  extracellular 
fibronectin.  Biochemical  evidence  for  such  an 
intracellular pool of fibronectin has been reported 
previously (32). 
A  pulse-chase experiment testing this hypothe- 
sis is described in Fig. 7. Cells were pre-incubated 
for 2 h with 0.2/~g/ml of cycloheximide to deplete 
intracellular  pools of fibronectin.  The cells  were 
then treated with  trypsin at concentrations suffi- 
cient to remove extracellular fibronectin, but not 
to detach the cells from the substratum. Cells were 
then incubated in normal culture medium without 
cycloheximide  for  2  h  to  permit  resynthesis  of 
fibronectin,  then returned  to medium containing 
cycloheximide to block further fibronectin synthe- 
sis. The cycloheximide pretreatment and trypsini- 
zation depleted both intracellular and extracellular 
fibronectin (Fig.  6c).  Removal of cycloheximide 
resulted in the reappearance of intracellular stain- 
ing, and a small  amount of surface staining (Fig. 
6d-f). The internal staining could be completely 
chased to fibrillar surface staining (Fig. 6g and h). 
Control cells maintained continuously in cyclohex- 
imide  after  trypsinization  did  not  show  either 
intracellular  or surface  fibronectin,  and omitting 
the final  incubation in cycloheximide resulted  in 
both  intracellular  and  extracellular  staining  (Fig. 
6i). 
In  addition,  the  overall  morphology  of  cells 
appeared to depend on the amount of extracellu- 
lar fibronectin. Cells containing only intracellular 
fibronectin were generally less flattened than cells 
with substantial  amounts of extracellular, fibrillar 
fibronectin,  which  were  significantly  flatter  and 
occupied more surface area  (cf. cell  areas in Fig. 
6c-f with  those  in  Fig.  6g-i).  However,  it  is 
conceivable  that  this  morphological  difference 
could also have resulted from alterations in inter- 
nal structural proteins. 
These results indicate that the intracellular pool 
of fibronectin serves as a precursor or antecedent 
to the fibronectin on the cell  surface. This intra- 
cellular  fibronectin  may therefore  be  located  in 
endoplasmic  reticulum  or Golgi  apparatus.  This 
procedure  may provide  a  means  to  synchronize 
and  to  characterize  the  sequential  biochemical 
alterations  in  fibronectin  during  processing  and 
secretion. 
Effects of  Anti-Fibronectin on 
Cell Morphology 
Chick fibroblasts treated with crude anti-fibro- 
nectin or with  50-100 ~g/ml of the affinity-puri- 
fied  antibody  added  directly  to  culture  media 
displayed rapid  alterations  in cell  shape  (Figs.  8 
and  9).  Within  10  rain,  cells  began  to  become 
more rounded or cylindrical and phase-refractile, 
and  the  cell  processes  became  blunter  and  less 
spread.  The alterations appeared to be complete 
within 30 rain (Fig. 8a-e). These changes in cell 
shape  were  quantitated  by  measuring  the  pro- 
jected area of cells fixed with glutaraldehyde-par- 
aformaldehyde at intervals after addition of anti- 
fibronectin. Mean cell area decreased by approxi- 
mately  one-third,  and  the  changes  were  nearly 
complete within 20 min (Fig. 9). Equal amounts 
of control globulin or IgG  (pre-immune  or con- 
trol) were without effect (Fig. 8f). 
These  alterations  in shape were not accompa- 
nied  by  decreased  cell  viability  as  assayed  by 
exclusion of trypan blue  (Table  II). In addition, 
the  antibody  treatment  did  not  affect  protein 
synthesis. Incorporation of [14C]leucine (1  /~Ci/ml 
for 3  h) into TCA-precipitable  material was not 
affected: untreated cultures, 66,620 cpm; treated 
with affinity-purified anti-fibronectin at 50/xg/ml, 
70,020 cpm: and control non-immune goat IgG, 
71,050  cpm  (values  are  means  of duplicate  cul- 
tures in 35-mm dishes). 
The morphological effects are readily reversed 
by rinsing cultures with fresh medium. 2-3 h after 
removal of antibody and  incubation in medium, 
the  cells  reflattened  on the  substratum  (Fig.  8g 
528  THE  JOURNAL OF  CELL BIOLOGY" VOLUME 78,  1978 Fxau~  6  Intracellular  to  extracellular  transfer  of  fibronectin.  All  cells  were  fixed,  extracted  with 
acetone, and stained for fibronectin. (a) Cell treated with 2 p,g/ml of cycloheximide for 2 h. Note absence 
of intracellular, perinuclear staining. Arrow indicates fibrillar, extracellular fibronectin. (b) Cell treated 
with 2/zg/ml puromycin for 2 h. (c) Cell treated for 2 h with 0.2/,~g/ml of cycloheximide, then trypsinized 
with 2  /~g/ml of crystalline trypsin for 10 min at 37~  in serum-free medium.  (d) 2 h after removal of 
cycloheximide. "(e) 2 hr after removal of cycloheximide, focused on perinuclear region. (f) Same cell as 
previous picture, but focused on substratum to show tortuous fibrillar staining (arrow). (g) 2 h without, 
then  a  further 2  h  with cycloheximide, showing fibrillar extracellular fibronectin (arrows); the diffuse 
staining on this cell was due to fibronectin higher on the cell that is out of focus. (h) 2 h without, then 2 h 
with cycloheximide.  (i)  4  h  without cycloheximide; note  substantial amounts of both perinuclear and 
fibrillar staining. N  =  nucleus, I  =  intracellular fibronectin. Fig. 6a and b are ￿  520; Fig. 6c-i are x  820. 
Bars, 25 p,m. 
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incubated in fresh  medium containing anti-fibro- 
nectin,  did  not  show  a  restoration  of  normal 
morphology (Fig. 8i). 
Fab  fragments  of  anti-fibronectin  were  also 
effective in producing these morphological altera- 
tions,  indicating that  cross-linking of antigen by 
multivalent antibody  is  not  necessary  for  these 
effects  on  cell morphology  (Fig.  8j).  The  mean 
cell area of cells treated for 60 min with these Fab 
fragments  of  anti-fibronectin was  decreased  by 
TABLE  I 
Effects of Cycloheximide on Intracellular 
Fibronectin  Staining 
Experimental  Intracellular  fluores- 
condition  cence present 
% of cells 
Untreated  85 
Cycloheximide 60 min  15 
Cycloheximide  120 min  2 
Reversal 60 min  77 
Reversal 120 min  86 
0.2  ~g/ml of cycloheximide  was  added to low-density 
(2-3  x  104/cm  2)  chick  fibroblasts in  regular  culture 
medium.  For  testing  reversibility,  the  cultures  were 
incubated in cycloheximide  for 2 h, washed  five times, 
then incubated in medium without cycloheximide.  300 
cells were scored  for each  experimental condition after 
fixing and staining for fibronectin using affinity-purified 
anti-fibronectin  and indirect immunofluorescence. 
Trypsin  I  Rinse 
+C2h  I  10min 
(+C) 
FIGURE  7 
37%  in  comparison  to  controls:  this  effect  is 
similar in magnitude to the effects of intact anti- 
fibronectin. 
The  alterations  in  morphology  produced  by 
anti-fibronectin are similar to those observed after 
transformation of chick fibroblasts by the Schmidt- 
Ruppin strain of Rous sarcoma virus (Fig.  8k), 
with  the  exception  of  the  appearance  of  large 
vacuoles in the transformed chick cells. The anti- 
body has little or no effect on the morphology of 
these transformed chick cells, which are deficient 
in fibronectin (Fig. 8/). Rounded cell morphology 
is  characteristic  of  many  cells  after  malignant 
transformation (33, 53). 
Similar antibody-induced changes  in morphol- 
ogy  of untransformed chick  cells were  observed 
using  glass  or  plastic  substrata,  although  cells 
cultured on plastic often required up to twice the 
concentration of antibody to produce  equivalent 
effects:  this difference  may  be  due  to  increased 
adhesiveness  of  the  cells  to  the  tissue  culture 
plastic.  Similar  morphological  alterations  were 
also seen if the cells were treated with the original 
crude  antisera  (1:10  dilution) after  it  had  been 
heat-inactivated at  56~  for  30 min. Crude pre- 
immune  or  non-immune control  antisera,  anti- 
fibronectin  preabsorbed  with  fibronectin,  anti- 
myosin antiserum, or anti-chicken gizzard filamin 
did  not  result  in  significant  morphological 
changes. 
|-C2h 
+C 4h  "?" 
Summary of experiment analyzing intracellular fibronectin. C =  cycloheximide,  0.2/zg/ml in 
culture  medium.  Asterisks  indicate times  at  which  cultures were  fixed  and  stained for  fibronectin; 
superscript  letters indicate which micrographs  in Fig. 6 correspond to these time-points. 
FIGURE 8  Effects  of anti-fibronectin on morphology of chick  embryo fibroblasts. (a)  Control chick 
fibroblasts.  (b) Cells  treated  with  crude  anti-fibronectin antiserum diluted to  1:10  in regular culture 
medium, 30 min. (c) Treated with 50/xg/ml of affinity-purified  anti-fibronectin for 10 min. (d) Treated 
for 20 rain. (e) Treated for 60 min. (f) Treated with 50/xg/ml of affinity-purified IgG fraction of control 
serum for 60 min. (g) Reversal experiment: treated with 50/zg/ml of affinity-purified  anti-fibronectin  for 
60 min, then rinsed five times and incubated in regular medium for 2 h. (h) Reversal experiment, 3 h. (i) 
Mock reversal:  50  tzg/ml of affinity-purified  anti-fibronectin added back to medium after rinsing five 
times, then incubated 3 more hours. (j) Treated with 100 /.tg/ml of affinity-purified  anti-fibronectin Fab 
for 60 min. (k) Chick fibroblasts transformed by the Schmidt-Ruppin strain of Rous sarcoma  virus.  (l) 
Transformed chick fibroblasts treated with  affinity  purified anti-fibronectin, 50  /xg/ml for  1 h.  Phase 
contrast, x  190. Bar, 50/~m. 
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FIGURE 9  Effects of anti-fibronectin on cell area. Cells 
were  treated with  50  g,g/ml of afffinity-purified anti- 
fihronectin or control IgG, then fixed and stained with 
methylene blue. Cell areas outlined on the plane of the 
substratum  as viewed from  above were  determined as 
described  in Materials  and Methods.  (e) treated with 
anti-fibronectin:  (O) treated with control IgG. 
Redistribution of Fibronectin by Antibody 
Chick  embryo  fibroblasts were  incubated  for 
varying intervals of time with 50 p.g/ml of affinity- 
purified anti-fibronectin added to the culture me- 
dium,  then  rinsed with  PBS,  fixed, and  stained 
with fluorescein-labeled anti-antibody. After 20- 
30 min of incubation with anti-fibronectin, when 
the morphological changes described above were 
nearly complete, the anti-fibronectin remained in 
fibrillar  patterns,  primarily  under  cells.  These 
fibrils,  however,  often  appeared  more  tortuous 
and generally shorter (Fig. 10a). 
After 40-60 min, the fibrillar patterns became 
more  distorted,  and  the  labeling  of  fibronectin 
began to redistribute to the dorsal surface of cells 
(the surface farthest from the substratum). Small 
aggregates of fibronectin were found on the lateral 
and dorsal surfaces of cells (Fig. 10b). Over the 
next  2  h,  the  fibronectin  redistributed to  large 
aggregates  on  the  dorsal  surfaces  of  cells,  and 
many cells displayed "caps" of well-circumscribed, 
brightly fluorescing material confined to the tops 
of cells (Fig. 10c and d). These caplike aggregates 
appeared to have  a  fibrillar substructure,  appar- 
ently because of compression of fibrillar strands of 
fibronectin. Such caps often extended 10-20  tzm 
up from the upper surfaces of cells, but sloughed 
caps were never seen. 
Although marked redistribution of flbronectin 
always occurred after antibody treatment of cul- 
tures of cells with minimal cell-cell contact, treat- 
ment of parallel cultures of confluent cells resulted 
in only minimal fibronectin redistribution even at 
high  antibody concentrations  (250  /~g/ml). This 
resistance to redistribution was correlated with the 
formation of extensive extracellular fibrillar mesh- 
works.  For  example,  the  fibronectin fibrils sur- 
rounding groups of cells that touched one another 
in subconfluent cultures remained relatively intact 
after antibody treatment, whereas marked redis- 
tribution of fibronectin occurred on  neighboring 
groups of cells that were not in contact. 
The  redistribution process on  single cells was 
quantitated by determining the numbers of cells 
with "caps" (>90-95%  of fluorescent staining in 
a  single,  well-circumscribed mass  over  the  cell 
nucleus), "redistributed" (>50%  of the label on 
the dorsal surface of cells), or still diffuse (>50% 
on the ventral surface, although usually in disarray 
similar to or more than in Fig. 10a. The rate of 
redistribution of fibronectin is substantially slower 
than the rapid initial effects on cell morphology, 
and is minimal for 1 h  (Fig. 11). After 3 h, 36% 
of the  cells are "capped",  and  68%  have  major 
redistribution of label. 
"Capped" fibronectin was not ingested in signif- 
icant amounts.  After exposure of live chick em- 
bryo fibroblasts (CEF) to anti-fibronectin for 3 h, 
cells were fixed and made permeable to antibody 
with  acetone.  Staining with  either fluorescein-la- 
TABLE  II 
Effect of Anti-Fibronectin  Antibodies  on Cell 
Viability 
Antibody  Concentration  Time  Viability 
h  % 
Anti-fibronectin  se-  1:10  3  98.2 
rum 
Pre-immune serum  1:10  3  98.4 
Affinity-purified anti-  200/zg/ml  8  98.6 
fibronectin 
Affinity-purified con-  200/xg/ml  8  98.4 
trol IgG 
Affinity-purified Fab  100 p,g/ml  3  98.0 
Low-density chick embryo fibroblasts  (2-3  ￿  104/cm  ~) 
were incubated with antibody in regular culture medium 
as indicated, then assayed for viability by incubating for 
10 rain in 0.1% trypan blue and scoring a total of 500 
cells per treatment. 
532  Tr~  JOURNAL  OF  CELL  BIOLOGY" VOLUME  78,  1978 Fmu~  10  Antibody-induced redistribution of fibronectin. (a-c) Cells were incubated with 50 txg/ml of 
affinity-purified anti-fibronectin for the indicated times, fixed, and stained with anti-antibody labeled with 
fluorescein. (a) Chick fibroblast 30 min after treatment with anti-fibronectin; dark field. (a') Same field, 
focused on substratum; immunofluorescence. (b) 60 rain after treatment with anti-fibronectin, focused on 
substratum.  (c) 120 min in anti-fibronectin; focused on substratum; note minimal amounts of fibronectin 
remaining under  cells  on  substratum  (arrows).  (c')  Same  field, focused on caplike structures.  "c" on 
dorsal surfaces of cells.  (d) 3 h in anti-fibronectin globulin directly coupled to fluorescein as described in 
Materials and Methods; focused on substratum.  (d') Same field, focused on caplike structure on dorsum 
of cell. (e) Cell incubated with 50 p,g/ml of affinity-purified  anti-fibronectin for 3 h, then extracted with 
acetone  and  incubated  with  fresh  50  p,g/ml  of anti-fibronectin,  then  with  anti-antibody  coupled  to 
fluorescein; focused on substratum.  (e') Same field, focused on dorsal "cap". (f) Cell in 2 ￿  10  -3 M  KCN 
while treated with 50 p,g/ml of affinity-purified  anti-fibronectin, focused on substratum. Note retention of 
fibrillar pattern and absence of aggregates or redistribution, c =  caplike structure.  ￿  520. Bar, 25/~m. 
beled rabbit  anti-goat  IgG or a  sequence of anti- 
fibronectin,  then  with  the  second  antibody,  did 
not reveal increased intracellular fibronectin (Fig. 
10e).  Moreover,  anti-fibronectin  labeled directly 
with  fluorescein  is  not  detectable  intracellularly 
after  treatment  of living chick cells for  3  h  (Fig. 
10d).  Positive controls for these experiments con- 
sisted  of treatment  of chick cells with  100  p.g/ml 
of fluorescein-labeled concanavalin A, which was 
readily ingested into intracellular vesicles. 
The  redistribution  is  inhibited  by  metabolic 
inhibitors,  such  as low temperature,  cyanide, and 
partially by azide (Figs.  10land  12). The experi- 
ments  with  cold  were  complicated  by  marked 
rounding  of  the  cells,  which  resulted  in  many 
examples  of cells  that  had  retracted  away  from 
fibronectin,  that  remained  on  the  substratum. 
These  cells were  not  included  in  the  determina- 
tions  of  redistribution,  inasmuch  as  they  would 
have  resulted  in  an  even higher apparent  inhibi- 
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FIrURE 11  Effects  of anti-fibronectin on the distribution of extracellular  fibronectin. Cells in regular 
culture medium were treated with 50/xg/ml of affinity-purified  anti-fibronectin  or with control lgG, then 
fixed at regular intervals and stained with anti-antibody  labeled with fluorescein. For each time-point, 250 
cells were scored as described in the text, and the percent of cells in each category was calculated.  Filled 
symbols indicate anti-fibronectin;  open symbols indicate control IgG. (r-q) capped, (A) redistributed, and 
(￿9  diffuse (see text for criteria). 
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FIGURE  12  Effects  of  inhibitors  on  antibody-induced 
redistribution of fibronectin.  Subcontinent chick fibro- 
blasts  were  fixed  without  treatment  ("untreated")  or 
treated with  50  p,g/ml affinity-purified  anti-fibronectin 
for 3 h in the presence of the inhibitors indicated at the 
following concentrations: potassium cyanide, 2  ￿  10 -a 
M; sodium azide, 1 x  10 -2 M; cytochalasin  B, 10 /zg/ 
ml; colchicine,  1 ￿  10 -4 M. Abscissa shows the percent 
of cells  with  caps  (dark bars) or partial redistribution 
(cross-hatched  bars). 
tion  of  redistribution  because  of  an  apparently 
trivial mechanism. 
The antibody-induced redistribution is inhibited 
only slightly by either 10/xg/ml of cytochalasin or 
10  -4  M  colchicine  alone.  This  concentration  of 
cytochalasin  resulted  in  cell  rounding  and  the 
typical bizarre, arborized pattern of cell processes 
characteristic  of  many  cytochalasin-treated  cell 
types (51).  The fibronectin patterns were  conse- 
quently distorted,  but 50%  of the cells still pos- 
sessed dorsally located fibronectin (Fig.  12).  Cy- 
tochalasin-treated cells eventually lose substantial 
amounts of fibronectin (2, 25). Colchicine-treated 
cells had  fewer  elongated processes,  and tended 
to  be  circular  (46).  After  anti-fibronectin treat- 
ment, label was found in the characteristic dorsal 
locations  in  the  majority  of  the  cells  (60%). 
Combining the  cytochalasin  and  colchicine  pre- 
vented redistribution (Fig. 12). 
Transformation and Fibronectin 
After  transformation  by  the  Schmidt-Ruppin 
strain of Rous sarcoma virus, antibody staining of 
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tracellular fibrillar and  the  intracellular, perinu- 
clear  granular forms of fibronectin appear  to  be 
decreased  (Fig.  13a).  The  direct  relationship of 
these alterations to transformation was examined 
using the temperature-sensitive ts68 strain of Rous 
sarcoma virus, which exhibits a  transformed phe- 
notype at 36~  and an apparently normal pheno- 
type at 41~  (20). Fibronectin is also decreased in 
both extracellular and intracellular locations when 
cells infected by ts68 are maintained at 36~  the 
temperature  permissive  for  transformation  (Fig. 
13c). 
In studies of dense cultures of chick fibroblasts 
infected  by  this  virus,  Wartiovaara  et  al.  (48) 
reported  that  substantial amounts of the  "SFA" 
(surface  fibroblast antigen; 220,0000  plus an ap- 
parent  150,000-dalton  component)  appeared  to 
FmugE  13  Alterations in fibronectin after transformation. Immunofluorescence microscopy.  (a) Chick 
embryo fibroblasts transformed by Schmidt-Ruppin strain of Rous sarcoma virus; acetone-extracted. Note 
decreases  in both intracellular and fibrillar extracellular fibronectin and smaller cell area compared to Fig. 
5a  (both  15-s  exposures  of  parallel  cultures).  (b)  Chick  embryo  fibroblasts  transformed  by  the 
temperature-sensitive mutant ts68, 6 h after shift from 36  ~ to 41~  (c) Cells transformed by ts68,  48 h 
after shift from 41 ~ to 36~  (d and d') Cells transformed by ts68, 6 h after shift from 41  ~ to 36~  Dark 
field  (d)  and immunofluorescence (d').  Note extensive loss of fibronectin onto substratum in trailing 
"tracks" (arrowheads).  x  520. Bar, 25 p,m. 
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shift,  and  remained  there  until  the  cells  were 
passaged with trypsin. Studies of sparser cultures 
in which it is possible to follow the fate of fibro- 
nectin  from  individual  cells  confirm  and  clarify 
these findings. Much  of the fibronectin becomes 
dissociated from the cells during the rapid shape 
changes that occur upon temperature shift to the 
permissive  temperature,  and  the  fibronectin re- 
mains behind on the substratum while cells retract 
or move away (Fig. 13d'). This loss of fibronectin 
and the alterations in cell morphology are promi- 
nent 4-6 h after the temperature shift. 
In contrast, cells shifted from 37 ~ to 41~  (the 
temperature  nonpermissive  for  transformation) 
rapidly  regain  fibronectin  fibrils,  which  remain 
closely  associated with  the  cells  as  on  untrans- 
formed chick cells (Fig. 13b'). 
Evaluation o  f Fibronectin 
"Reconstitution" 
We previously showed that  addition of exoge- 
nous  cellular  fibronectin  CSP  to  a  variety  of 
transformed  cells would  restore  a  more  normal 
morphology, surface  architecture, and social be- 
havior  (53,  54,  60).  All  of  the  reconstituted 
fibronectin was on  the  exterior of the cell, inas- 
much  as gentle trypsinization removed all exoge- 
nous label (60). Similar experiments were recently 
reported by Ali et al. (3) using fibronectin added 
to a transformed hamster cell line. 
The organization of this reconstituted fibronec- 
tin was examined using affinity-purified anti-fibro- 
nectin. The fibronectin is located in fibrils under 
and  between cells, and  organizes into  a  fibrillar 
extracellular matrix in confluent cells, as on nor- 
mal cells (Fig. 15c') (3). In sparse cultures, some 
amorphous aggregates are seen directly attached 
to  the  substratum  in  the  absence  of cells  (Fig. 
14b).  In  many  instances,  the  fibronectin under 
cells is oriented towards the periphery of cells, as 
if holding the cell in a  spread configuration (Fig. 
14b'). 
Incubation  of  "fibronectin-reconstituted" cells 
with  affinity-purified anti-fibronectin results in a 
reversion back to a rounded cell morphology (this 
antibody also blocked the initial effects of fibro- 
nectin  if  added  with  the  exogenous  fibronectin 
[60]).  Further  incubation  with  the  antibody re- 
sulted in redistribution or capping of the fibronec- 
tin, as on untransformed chick cells (Fig. 14d-f). 
The flbronectin is therefore appearing on the cell 
surfacein a grossly normal pattern consistent with 
a role in adhesion to both cell and substratum (3, 
54).  Similar to normal fibronectin, reconstituted 
fibronectin  is  also  subject  to  antibody-induced 
redistribution. 
DISCUSSION 
Specificity of the Antibody 
Isolated cellular fibronectin is not soluble under 
conditions usually used to evaluate antibody spec- 
ificity (56), which necessitated the use of modified 
double  immunodiffusion  and  immunoprecipita- 
tion  procedures in  which  fibronectin or cell ho- 
mogenates  are  first  solubilized at  pH  11,  then 
assayed at neutral pH.  We have also used a new 
procedure for detecting antigens separated in SDS 
gels (31).  Antisera produced against either elec- 
trophoretically or chromatographically purified fi- 
bronectin  were  specific for  fibronectin by all of 
these  procedures  (see  reference  31  and  this pa- 
per). No differences in fluorescence staining pat- 
terns or in capacity to produce altered cell shape 
or fibronectin redistribution could be detected in 
comparisons  of affinity-purified antibodies from 
either of these sources of antiserum. 
There is no evidence that these antibodies can 
cross-react  with  a  150,000-dalton  polypeptide 
(22)  previously thought  to  associate with  SF210 
(fibronectin). To further ensure that the antibody 
was monospecific, it was affinity purified against 
the  dimer  fraction  of  isolated  fibronectin.  The 
antibodies used  in  this study did not cross-react 
with calf cold insoluble globulin in culture media. 
Localization o  f Fibronectin 
In cultures of chick fibroblasts at low cell den- 
sity, fibronectin is localized to extracellular fibril- 
lar structures under and between the cells, as well 
as  to  intracellular, diffusely granular  structures. 
This intracellular localization is apparently due to 
recently synthesized fibronectin located in  intra- 
cellular pools such  as endoplasmic reticulum be- 
fore export to the cell surface. By isotopic labeling 
procedures,  such  pools  were  found  to  contain 
-10%  of the  fibronectin synthesized over 24  h 
(32). 
Treatment  of cells with  the  protein  synthesis 
inhibitors cycloheximide or puromycin results in a 
progressive decrease in this intracellular immuno- 
fluorescent staining, which is complete in 2 h. The 
staining returns after removal of the protein syn- 
thesis inhibitors. These findings suggest that it will 
be  possible  to  analyze  the  kine~tics  and  exact 
pathways of secretion of this glycoprotein. 
536  THE  JOURNAL  OF  CELL  BIOLOGY ￿9 VOLUME  78,  1978 FIGURE 14  Localization and  redistribution of cellular fibronectin reconstituted on  transformed cells. 
SV1 cells were incubated with 25 /xg/ml of purified fibronectin in regular culture medium for 48 h, then 
fixed (b-c) or incubated with anti-fibronectin before fixation (d-f). (a-c) Dark field. (a'-c') Immunoflu- 
orescence of same fields.  (a  and a') Control SV1  cells without fibronectin. (b  and b') Semiconfluent 
culture of cells plus fibronectin. Numbers indicate locations of nuclei. (c and c') Confluent culture plus 
fibronectin. (d) Two  cells with reconstituted fibronectin, incubated for 3  h  with 50  /.tg/ml of afffinity- 
purified anti-fibronectin, focused on the substratum. Arrows indicate fibrillar fibronectin remaining in 
cells. (d') Same field as Fig.  14d, focused on caplike aggregates (c) on dorsal (upper) surface. (e) Cell 
plus 50/xg/ml of anti-fibronectin for 3 h, focused on substratum. (e') Focused on dorsal surface. (f) Cell 
plus 50/xg/ml of anti-fibronectin for 3 h, focused on substratum; note minimal amounts of staining. (f') 
Focused on dorsal surface. ￿  520. Bar, 25/~m. 
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bridging between cells becomes more prominent 
(6,  28,  44).  Eventually cells are enmeshed  in  a 
complex fibrillar network. The intracellular stain- 
ing in cells made permeable with acetone becomes 
much  less prominent,  and  is detected only with 
difficulty in heavily confluent cells. These results 
suggest that the proportion of fibronectin on the 
cell surface increases at confluence, which would 
be  consistent with  the  reported increases in  the 
accessibility of LETS protein (galactoprotein a) of 
Nil cells to surface labeling procedures at conflu- 
ence (11,  16) as well as the greater recoveries of 
fibronectin after treatment of confluent cells with 
0.2 M urea (58). 
Vaheri, Ruoslahti, and co-workers have exten- 
sively studied a cell surface antigen called "SFA" 
(22, 48). This antigen was initially identified using 
antibody prepared against papain digests of cell 
surface proteins. The SFA reportedly consisted of 
at least two cellular proteins of apparent mol wt 
150,000  and  210,000  on  SDS  gels, which  were 
thought  to contain a  common antigenic determi- 
nant. More recent work from that laboratory has 
utilized antibody against the human  plasma pro- 
tein  Clg,  which  is  reportedly  immunologically 
indistinguishable from SFA. These antibodies also 
localize to complex extracellular fibrillar patterns 
and  intracellular granular staining in cultured fi- 
broblasts (39, 44). Mautner and Hynes (28) have 
recently  described  similar  extracellular  fibrillar 
patterns on hamster Nil cells. 
The  localization  of  fibronectin  between  cells 
and substratum as well as between cells is consist- 
ent with a  role as an adhesive protein helping to 
maintain normal cell morphology (6, 28, 55). The 
similar localization of artificially reconstituted fi- 
bronectin on  the  surfaces of fibronectin-treated, 
morphologically "reverted" transformed cells also 
supports this hypothesis. 
Antibody Effects on Cell Morphology 
Another test of the  role  of fibronectin in  cell 
shape  is to treat living cells with anti-fibronectin 
and  to determine  its effects on  cell morphology 
and adhesion. Treatment  of chick embryo fibro- 
blasts with affinity-purified anti-fibronectin results 
in  rapid  cell  rounding  and  a  blunting  of  cell 
processes that is nearly complete in 20 rain. The 
effects are  specific and  reversible. The  resultant 
cell morphology is similar to  that of chick fibro- 
blasts transformed by Rous sarcoma virus and to 
that  of  many  other  transformed  cells  that  are 
deficient in cellular fibronectin. 
These  effects of anti-fibronectin are separable 
from the "capping" process (see below) by differ- 
ences in kinetics (20 min vs. 2-3 h). In addition, 
monovalent  antibody  also  produces  the  same 
rapid effects on  cell morphology. The  effects of 
anti-fibronectin or~ cell morphology are consistent 
with  the  notion  that  cell surface fibronectin is a 
major  adhesive  molecule  of  chick  fibroblasts. 
However,  the  partial  residual  adhesiveness  of 
chick cells treated with  anti-fibronectin or trans- 
formed by Rous sarcoma virus (neither of which 
results in cell detachment) suggests that other cell- 
substratum  adhesive  mechanisms  also  exist  in 
these cells. 
Antibody-Induced Redistribution 
o  f Fibronectin 
The redistribution of fibronectin in the presence 
of anti-fibronectin is similar to "capping" of con- 
canavalin  A  and  histocompatibility antigens  on 
lymphocytes  (29,  42)  or  on  transformed  fibro- 
blastic cells (10,  41)  in  that  it results in a  well- 
circumscribed, supranuclear "cap" of antigen-an- 
tibody complexes. Fibronectin redistribution ap- 
pears to be  significantly slower than  these  other 
types of capping (2-3 h vs. 5 min on lymphocytes 
and  20-40  min on transformed cells). However, 
capping  of a  recently isolated glucose-regulated 
glycoprotein on  untransformed  fibroblastic cells 
also required antibody treatment for 2-3 h  (36). 
"Capping" of fibronectin occurred only on iso- 
lated  cells  and  did  not  occur  after  fibronectin 
formed  an  extracellular matrix  as cells grew  to 
higher  population  densities, suggesting  that  for- 
mation  of extensive  cell-cell and  cell-matrix at- 
tachments results in a  stable meshwork of fibro- 
nectin that is resistant to reorganization. In con- 
trast to lymphocytes, fibronectin redistribution on 
fibroblasts  was  not  accompanied  by  detectable 
ingestion  of  antibody-antigen complexes.  How- 
ever, the redistribution of fibronectin was similar 
to  lymphocyte capping in  its sensitivity to meta- 
bolic inhibitors, and to the combination of colchi- 
cine and cytochalasin. 
However, such antibody-induced redistribution 
was  not  found  with  hamster  Nil  cells  (28).  In 
contrast,  fibronectin fibrils of human  fibroblasts 
were also recently found to be disrupted by treat- 
ment with antibodies against human cold insoluble 
globulin, resulting in "patches" but not in capping 
(26).  Whether that  redistribution requires meta- 
bolic  processes  or  is  directly  analogous  to  the 
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The  extensive  antibody-induced  redistribution 
of fibronectin on chick embryo cells indicates that 
fibronectin  can  be  translocated  laterally  in  the 
plane  of the  membrane.  This  redistribution  in- 
volves a process requiring metabolic energy. Iso- 
lation of fibronectin "caps" might possibly provide 
information about plasma membrane binding sites 
for fibronectin,  and  the  mechanisms of capping. 
It is important to note that direct measurements 
of the lateral mobility of fibronectin showed that 
fibronectin is relatively immobile compared with 
other membrane-associated proteins that are rap- 
idly  mobile  (38).  However,  the  present  results 
indicate that slow, directed movement of fibronec- 
tin will  eventually occur in the presence of anti- 
body.  Whether  the  antibody-induced  redistribu- 
tion  is  due  to  bulk  membrane  flow  (1)  or  to 
submembranous,  cytochalasin-  and  colchicine- 
sensitive  microfilament  and  microtubule  com- 
plexes (5, 9, 29, 51) remains to be determined. 
It is also important to note that a converse type 
of relationship between adhesive fibronectin mol- 
ecules  and  the  organization  and  distribution  of 
microfilament  bundles  of  cells  may  also  exist. 
Treatment  of untransformed cells  with  proteases 
that  hydrolyze  fibronectin  results  in  a  loss  of 
microfilament  bundles,  and the  reconstitution of 
fibronectin on transformed fibroblasts missing this 
protein  results  in  a  restoration  of microfilament 
bundles (3, 52). 
Transformation  and Fibronectin 
As  reported  previously by Wartiovaara  et  al. 
(48),  who utilized  antibodies  against  the  "SFA" 
complex, antibody staining for extracellular fibro- 
nectin  is  decreased  after  viral  transformation  of 
chick fibroblasts.  The  decreases we find in both 
the  intracellular  and  the  extracellular  pools  of 
antigenic fibronectin  staining  are  consistent with 
the  decreases  in  both  pools previously reported 
using radioactive labeling procedures (32). These 
decreases  in  isotopic  labeling  were  due  to  (a) 
decreased  biosynthesis  (the  major  factor),  (b) 
increased protein degradation,  and  (c) increased 
loss of intact fibronectin from the cell surface into 
the culture medium. The loss of fibronectin from 
the cell body to the substratum seen in this paper 
using fluorescent antibody procedures soon after 
shifting cells infected with ts68 to the temperature 
permissive  for transformation  may represent  the 
last factor (c), which may play a significant role in 
the cell shape changes after temperature shift (18, 
45).  Such  a  decreased  capacity of cells  to  bind 
cellular fibronectin may account for examples of 
incomplete restoration of normal cell morphology 
to certain transformed cell lines in previous recon- 
stitution experiments (54, 60). These results sug- 
gest  that  it  may be  useful  to search  for cellular 
receptors  for  fibronectin  that  are  altered  after 
transformation. 
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